Passage Bio, Inc. Common Stock (NASDAQ: PASG) last traded at $4.46, down 1.98% on the session. The quote above updates while this page is open; the figures below are drawn from Passage Bio, Inc. Common Stock’s own filings and are restated only when a new one is published.
Passage Bio, Inc. Common Stock trades on NASDAQ under the ticker PASG. Its market capitalisation is $14.35 million.
Valuation measures for Passage Bio, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $14.35M |
|---|---|
| Enterprise value | $10.92M |
| Price / book | 3.22 |
| Beta | 2.75 |
Trailing-twelve-month figures tagged in Passage Bio, Inc. Common Stock's XBRL filings with the SEC.
| Net income (TTM) |
|---|
| -$36.11M |
| EPS (TTM) | -$11.32 |
|---|
| Return on equity | -810.41% |
|---|
| Cash | $24.16M |
|---|
Range and volume for PASG over the past 52 weeks.
| 52-week high | $20.00 |
|---|---|
| 52-week low | $3.29 |
| Volume | 2.0K |
| Average volume | 26.4K |
| Previous close | $4.55 |
Invest a chosen dollar amount in Passage Bio, Inc. Common Stock with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell PASG.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.